Drug-induced psychosis in Parkinson disease

Phenomenology and correlations among psychosis rating instruments

Kelvin L. Chou, Susan Messing, David Oakes, Peter D. Feldman, Alan Breier, Joseph H. Friedman

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objectives: To describe further the phenomenology of drug-induced psychosis (DIP) in patients with Parkinson disease (PD) and assess which items on two common psychosis rating instruments-the Brief Psychiatric Rating Scale (BPRS) and the Neuropsychiatric Inventory (NPI)-are the best measure of DIP by comparing them with the Clinical Global Impression Scale (CGIS). Methods: Baseline data from two placebo-controlled, double-blind studies of olanzapine in PD patients with DIP were collected and analyzed. Results: A total of 157 of 160 patients had hallucinations, with visual hallucinations being the most common (97% of subjects), followed by auditory (48%), tactile (23%), and olfactory (16%). Seventy-six percent of subjects experienced delusions, and all types of delusions occurred with relatively equal frequency. The CGIS correlated with suspiciousness, hallucinatory behavior, unusual thought content, and hostility on the BPRS; and delusions, hallucinations, agitation, aberrant motor behavior, and sleep on the NPI. Conclusion: Nonvisual hallucinations and delusions may occur more frequently in DIP than previously thought. These symptoms, plus agitation and hostility, may ultimately be the best measure of DIP in patients with PD.

Original languageEnglish (US)
Pages (from-to)215-219
Number of pages5
JournalClinical Neuropharmacology
Volume28
Issue number5
DOIs
StatePublished - Sep 2005

Fingerprint

Substance-Induced Psychoses
Delusions
Psychotic Disorders
Hallucinations
Parkinson Disease
Brief Psychiatric Rating Scale
Hostility
olanzapine
Equipment and Supplies
Touch
Double-Blind Method
Sleep
Placebos

Keywords

  • Delusions
  • Hallucinations
  • Parkinson disease
  • Psychosis
  • Rating scales

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Drug-induced psychosis in Parkinson disease : Phenomenology and correlations among psychosis rating instruments. / Chou, Kelvin L.; Messing, Susan; Oakes, David; Feldman, Peter D.; Breier, Alan; Friedman, Joseph H.

In: Clinical Neuropharmacology, Vol. 28, No. 5, 09.2005, p. 215-219.

Research output: Contribution to journalArticle

Chou, Kelvin L. ; Messing, Susan ; Oakes, David ; Feldman, Peter D. ; Breier, Alan ; Friedman, Joseph H. / Drug-induced psychosis in Parkinson disease : Phenomenology and correlations among psychosis rating instruments. In: Clinical Neuropharmacology. 2005 ; Vol. 28, No. 5. pp. 215-219.
@article{c2ca2ccffe0340ada8abcc3120c9cba6,
title = "Drug-induced psychosis in Parkinson disease: Phenomenology and correlations among psychosis rating instruments",
abstract = "Objectives: To describe further the phenomenology of drug-induced psychosis (DIP) in patients with Parkinson disease (PD) and assess which items on two common psychosis rating instruments-the Brief Psychiatric Rating Scale (BPRS) and the Neuropsychiatric Inventory (NPI)-are the best measure of DIP by comparing them with the Clinical Global Impression Scale (CGIS). Methods: Baseline data from two placebo-controlled, double-blind studies of olanzapine in PD patients with DIP were collected and analyzed. Results: A total of 157 of 160 patients had hallucinations, with visual hallucinations being the most common (97{\%} of subjects), followed by auditory (48{\%}), tactile (23{\%}), and olfactory (16{\%}). Seventy-six percent of subjects experienced delusions, and all types of delusions occurred with relatively equal frequency. The CGIS correlated with suspiciousness, hallucinatory behavior, unusual thought content, and hostility on the BPRS; and delusions, hallucinations, agitation, aberrant motor behavior, and sleep on the NPI. Conclusion: Nonvisual hallucinations and delusions may occur more frequently in DIP than previously thought. These symptoms, plus agitation and hostility, may ultimately be the best measure of DIP in patients with PD.",
keywords = "Delusions, Hallucinations, Parkinson disease, Psychosis, Rating scales",
author = "Chou, {Kelvin L.} and Susan Messing and David Oakes and Feldman, {Peter D.} and Alan Breier and Friedman, {Joseph H.}",
year = "2005",
month = "9",
doi = "10.1097/01.wnf.0000180228.77802.32",
language = "English (US)",
volume = "28",
pages = "215--219",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Drug-induced psychosis in Parkinson disease

T2 - Phenomenology and correlations among psychosis rating instruments

AU - Chou, Kelvin L.

AU - Messing, Susan

AU - Oakes, David

AU - Feldman, Peter D.

AU - Breier, Alan

AU - Friedman, Joseph H.

PY - 2005/9

Y1 - 2005/9

N2 - Objectives: To describe further the phenomenology of drug-induced psychosis (DIP) in patients with Parkinson disease (PD) and assess which items on two common psychosis rating instruments-the Brief Psychiatric Rating Scale (BPRS) and the Neuropsychiatric Inventory (NPI)-are the best measure of DIP by comparing them with the Clinical Global Impression Scale (CGIS). Methods: Baseline data from two placebo-controlled, double-blind studies of olanzapine in PD patients with DIP were collected and analyzed. Results: A total of 157 of 160 patients had hallucinations, with visual hallucinations being the most common (97% of subjects), followed by auditory (48%), tactile (23%), and olfactory (16%). Seventy-six percent of subjects experienced delusions, and all types of delusions occurred with relatively equal frequency. The CGIS correlated with suspiciousness, hallucinatory behavior, unusual thought content, and hostility on the BPRS; and delusions, hallucinations, agitation, aberrant motor behavior, and sleep on the NPI. Conclusion: Nonvisual hallucinations and delusions may occur more frequently in DIP than previously thought. These symptoms, plus agitation and hostility, may ultimately be the best measure of DIP in patients with PD.

AB - Objectives: To describe further the phenomenology of drug-induced psychosis (DIP) in patients with Parkinson disease (PD) and assess which items on two common psychosis rating instruments-the Brief Psychiatric Rating Scale (BPRS) and the Neuropsychiatric Inventory (NPI)-are the best measure of DIP by comparing them with the Clinical Global Impression Scale (CGIS). Methods: Baseline data from two placebo-controlled, double-blind studies of olanzapine in PD patients with DIP were collected and analyzed. Results: A total of 157 of 160 patients had hallucinations, with visual hallucinations being the most common (97% of subjects), followed by auditory (48%), tactile (23%), and olfactory (16%). Seventy-six percent of subjects experienced delusions, and all types of delusions occurred with relatively equal frequency. The CGIS correlated with suspiciousness, hallucinatory behavior, unusual thought content, and hostility on the BPRS; and delusions, hallucinations, agitation, aberrant motor behavior, and sleep on the NPI. Conclusion: Nonvisual hallucinations and delusions may occur more frequently in DIP than previously thought. These symptoms, plus agitation and hostility, may ultimately be the best measure of DIP in patients with PD.

KW - Delusions

KW - Hallucinations

KW - Parkinson disease

KW - Psychosis

KW - Rating scales

UR - http://www.scopus.com/inward/record.url?scp=27644532055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644532055&partnerID=8YFLogxK

U2 - 10.1097/01.wnf.0000180228.77802.32

DO - 10.1097/01.wnf.0000180228.77802.32

M3 - Article

VL - 28

SP - 215

EP - 219

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 5

ER -